TMEM16A, a Homoharringtonine Receptor, as a Potential Endogenic Target for Lung Cancer Treatment
Shuai Guo(Hebei University of Technology), Hailong An(Hebei University of Technology)
Cited by 34
Related Papers
CXCL5 activates CXCR2 in nociceptive sensory neurons to drive joint pain and inflammation in experimental gouty arthritis
|Nature Communications|2024|62
Self-healing pectin/cellulose hydrogel loaded with limonin as TMEM16A inhibitor for lung adenocarcinoma treatment
|International Journal of Biological Macromolecules|2022|45
Biodegradable hydrogel from pectin and carboxymethyl cellulose with Silibinin loading for lung tumor therapy
|International Journal of Biological Macromolecules|2023|27